Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
517 hedge funds and large institutions have $14B invested in Exact Sciences in 2020 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 165 increasing their positions, 179 reducing their positions, and 73 closing their positions.
21% more capital invested
Capital invested by funds: $11.5B → $14B (+$2.45B)
3.29% more ownership
Funds ownership: 88.48% → 91.77% (+3.3%)
8% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 73
1% more call options, than puts
Call options by funds: $248M | Put options by funds: $246M
1% more funds holding
Funds holding: 513 → 517 (+4)
0% more funds holding in top 10
Funds holding in top 10: 12 → 12 (0)
8% less repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 179
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$556M |
| 2 |
N
Natixis
Paris,
France
|
+$96.7M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$70.3M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$59.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$121M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$84.6M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$80.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$72.4M |
| 5 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$54.8M |
EXAS Hedge Fund Activity: Q3 2020 in Review
517 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2020, worth a combined $14B — up 21% from $11.5B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new EXAS positions and 73 closed out — a net gain of 6 holders — while 165 added to existing stakes and 179 trimmed.
The largest buyer was Capital World Investors, adding an estimated $556M. The largest seller was T. Rowe Price Associates, cutting an estimated $121M.
- 517 institutional investors held Exact Sciences (EXAS) as of Q3 2020, up from 513 in Q2 2020.
- Funds reported $14B of Exact Sciences stock for Q3 2020, up 21% quarter-over-quarter.
- 79 funds opened new Exact Sciences positions in Q3 2020 and 73 closed out, a net change of +6 holders.
- The largest Exact Sciences buyer in Q3 2020 was Capital World Investors, an estimated $556M added.
- The largest Exact Sciences seller in Q3 2020 was T. Rowe Price Associates, an estimated $121M sold.
Based on aggregated 13F filings for Q3 2020.